vs
Side-by-side financial comparison of Emerald Holding, Inc. (EEX) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $132.7M, roughly 1.1× Emerald Holding, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs -22.8%, a 30.6% gap on every dollar of revenue. On growth, Emerald Holding, Inc. posted the faster year-over-year revenue change (24.3% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $11.7M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -0.3%).
TVS Emerald Haven Realty Limited is an Indian real estate development company headquartered in Chennai, Tamil Nadu. A subsidiary of TVS Holdings, it specializes in sustainable residential communities and urban development projects.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
EEX vs NUTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $132.7M | $151.7M |
| Net Profit | $-30.2M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | -11.8% | 20.4% |
| Net Margin | -22.8% | 7.8% |
| Revenue YoY | 24.3% | -41.1% |
| Net Profit YoY | -692.2% | -80.8% |
| EPS (diluted) | $-0.15 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $132.7M | $151.7M | ||
| Q3 25 | $77.5M | $267.8M | ||
| Q2 25 | $105.5M | $244.0M | ||
| Q1 25 | $147.7M | $211.8M | ||
| Q4 24 | $106.8M | $257.6M | ||
| Q3 24 | $72.6M | $78.8M | ||
| Q2 24 | $86.0M | $76.1M | ||
| Q1 24 | $133.4M | $67.5M |
| Q4 25 | $-30.2M | $11.8M | ||
| Q3 25 | $-14.4M | $55.4M | ||
| Q2 25 | $-1.4M | $-17.7M | ||
| Q1 25 | $15.3M | $21.2M | ||
| Q4 24 | $5.1M | $61.6M | ||
| Q3 24 | $-11.1M | $-8.8M | ||
| Q2 24 | $-2.8M | $-364.0K | ||
| Q1 24 | $11.0M | $-364.0K |
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% | ||
| Q1 24 | — | 15.1% |
| Q4 25 | -11.8% | 20.4% | ||
| Q3 25 | -10.1% | 48.7% | ||
| Q2 25 | 9.7% | 13.8% | ||
| Q1 25 | 24.2% | 38.1% | ||
| Q4 24 | 19.5% | 44.4% | ||
| Q3 24 | -6.5% | 12.3% | ||
| Q2 24 | 7.4% | 7.0% | ||
| Q1 24 | 18.2% | 2.1% |
| Q4 25 | -22.8% | 7.8% | ||
| Q3 25 | -18.6% | 20.7% | ||
| Q2 25 | -1.3% | -7.3% | ||
| Q1 25 | 10.4% | 10.0% | ||
| Q4 24 | 4.8% | 23.9% | ||
| Q3 24 | -15.3% | -11.2% | ||
| Q2 24 | -3.3% | -0.5% | ||
| Q1 24 | 8.2% | -0.5% |
| Q4 25 | $-0.15 | $2.34 | ||
| Q3 25 | $-0.07 | $7.76 | ||
| Q2 25 | $-0.01 | $-2.95 | ||
| Q1 25 | $0.08 | $3.33 | ||
| Q4 24 | $0.01 | $11.56 | ||
| Q3 24 | $-0.05 | $-1.72 | ||
| Q2 24 | $-0.03 | $-0.07 | ||
| Q1 24 | $0.00 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $100.9M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $338.8M | $329.4M |
| Total Assets | $1.2B | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $100.9M | $185.6M | ||
| Q3 25 | $95.4M | $166.0M | ||
| Q2 25 | $156.4M | $96.7M | ||
| Q1 25 | $276.8M | $84.7M | ||
| Q4 24 | $194.8M | $40.6M | ||
| Q3 24 | $188.9M | $46.9M | ||
| Q2 24 | $193.2M | $40.8M | ||
| Q1 24 | $186.8M | $30.0M |
| Q4 25 | $338.8M | $329.4M | ||
| Q3 25 | $369.5M | $317.2M | ||
| Q2 25 | $389.4M | $235.3M | ||
| Q1 25 | $392.1M | $176.9M | ||
| Q4 24 | $385.9M | $132.4M | ||
| Q3 24 | $391.1M | $60.4M | ||
| Q2 24 | $407.6M | $62.7M | ||
| Q1 24 | $-90.7M | $63.0M |
| Q4 25 | $1.2B | $918.5M | ||
| Q3 25 | $1.2B | $964.5M | ||
| Q2 25 | $1.2B | $841.0M | ||
| Q1 25 | $1.2B | $761.9M | ||
| Q4 24 | $1.0B | $655.3M | ||
| Q3 24 | $1.1B | $438.5M | ||
| Q2 24 | $1.1B | $422.4M | ||
| Q1 24 | $1.1B | $404.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | $70.4M |
| Free Cash FlowOCF − Capex | $11.7M | $69.0M |
| FCF MarginFCF / Revenue | 8.8% | 45.5% |
| Capex IntensityCapex / Revenue | 0.5% | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $41.4M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.3M | $70.4M | ||
| Q3 25 | $1.8M | $99.5M | ||
| Q2 25 | $15.9M | $27.3M | ||
| Q1 25 | $12.6M | $51.0M | ||
| Q4 24 | $20.6M | $54.0K | ||
| Q3 24 | $9.1M | $6.8M | ||
| Q2 24 | $9.8M | $13.3M | ||
| Q1 24 | $7.3M | $3.1M |
| Q4 25 | $11.7M | $69.0M | ||
| Q3 25 | $1.5M | $99.2M | ||
| Q2 25 | $15.8M | $26.5M | ||
| Q1 25 | $12.4M | $50.9M | ||
| Q4 24 | $19.9M | $-341.0K | ||
| Q3 24 | $9.0M | $6.2M | ||
| Q2 24 | $9.6M | $12.7M | ||
| Q1 24 | $7.0M | $2.3M |
| Q4 25 | 8.8% | 45.5% | ||
| Q3 25 | 1.9% | 37.0% | ||
| Q2 25 | 15.0% | 10.9% | ||
| Q1 25 | 8.4% | 24.0% | ||
| Q4 24 | 18.6% | -0.1% | ||
| Q3 24 | 12.4% | 7.8% | ||
| Q2 24 | 11.2% | 16.7% | ||
| Q1 24 | 5.2% | 3.4% |
| Q4 25 | 0.5% | 0.9% | ||
| Q3 25 | 0.4% | 0.1% | ||
| Q2 25 | 0.1% | 0.3% | ||
| Q1 25 | 0.1% | 0.0% | ||
| Q4 24 | 0.7% | 0.2% | ||
| Q3 24 | 0.1% | 0.8% | ||
| Q2 24 | 0.2% | 0.7% | ||
| Q1 24 | 0.2% | 1.1% |
| Q4 25 | — | 5.95× | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.82× | 2.40× | ||
| Q4 24 | 4.04× | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EEX
| Connections Segment | $121.9M | 92% |
| Commerce Segment | $5.5M | 4% |
| Content | $5.3M | 4% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
